Skip to main content
Free research Free research Free assay review with research home and workspace preview
Quick search ChEMBL 36
Assay Detail

CHEMBL2340160

Review assay metadata, readout intent, target linkage, and publication context from the same page.

Binding
Inhibition of human recombinant PDE4B2 assessed as decrease in cAMP hydrolysis preincubated with substrate prior to enzyme addition measured after 30 mins by colorimetric assay method
11
Total Activities
11
Compounds Tested
1
Activity Types
0
Assay Parameters

Assay Information

Assay Type Binding
Organism Homo sapiens
Confidence 9 — Direct single protein target
Curated By Autocuration

Target

3',5'-cyclic-AMP phosphodiesterase 4B (CHEMBL275)
Type SINGLE PROTEIN
Organism Homo sapiens

Publication

Hybrids consisting of the pharmacophores of salmeterol and roflumilast or phthalazinone: dual β₂-adrenoceptor agonists-PDE4 inhibitors for the treatment of COPD.
Liu A, Huang L, Wang Z, Luo Z, Mao F, Shan W, Xie J, Lai K, Li X.
Bioorg Med Chem Lett (2013) 23 : 1548 -1552
PubMed 23375225 · DOI

Activity Statistics

Type Count Avg pChEMBL Best pChEMBL
IC50 11 6.65 9.10

Compounds Tested

Compound Name Phase Activities Best pChEMBL
CHEMBL193240 ROFLUMILAST 4.0 1 9.10
CHEMBL2335411 1 6.63
CHEMBL2335415 1 6.58
CHEMBL2335414 1 6.57
CHEMBL2335413 1 6.56
CHEMBL2335412 1 6.55
CHEMBL2335410 1 6.41
CHEMBL430893 (-)-ROLIPRAM 1 6.30
CHEMBL82318 1 6.28
CHEMBL2335409 1 6.22
CHEMBL2335408 1 5.96

Activity Data

Compound Name Type Rel. Value Units pChEMBL
CHEMBL193240 ROFLUMILAST IC50 = 0.8 nM 9.10
CHEMBL2335411 IC50 = 235.0 nM 6.63
CHEMBL2335415 IC50 = 263.0 nM 6.58
CHEMBL2335414 IC50 = 271.0 nM 6.57
CHEMBL2335413 IC50 = 278.0 nM 6.56
CHEMBL2335412 IC50 = 282.0 nM 6.55
CHEMBL2335410 IC50 = 394.0 nM 6.41
CHEMBL430893 (-)-ROLIPRAM IC50 = 500.0 nM 6.30
CHEMBL82318 IC50 = 520.0 nM 6.28
CHEMBL2335409 IC50 = 601.0 nM 6.22
CHEMBL2335408 IC50 = 1093.0 nM 5.96